Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium

Vaccine

Volumn 26, Issue 49, 2008, Pages 6212-6220

  Gahan, Michelle E ^a,b,c   Webster, Diane E ^b,d   Wijburg, Odilia L C ^a   Wesselingh, Steven L ^b,c   Strugnell, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Oral; Prior exposure; Salmonella; Vaccine vector

Indexed keywords

ANTIGEN; DNA VACCINE; PLASMID VECTOR; SALMONELLA TYPHIMURIUM BRD509 TETANUS TOXIN C FRAGMENT DNA VACCINE PAT153; SALMONELLA TYPHIMURIUM BRD509 TETANUS TOXIN C FRAGMENT EXPRESSION PLASMID PTETTAC4 VACCINE; SALMONELLA TYPHIMURIUM BRD509 VACCINE; TETANUS TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LIVER; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SPLEEN; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; PLASMIDS; SALMONELLA ENTERICA; SALMONELLA VACCINES; TETANUS TOXIN; TETANUS TOXOID; VACCINES, DNA;

EID: 55249097117     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.060     Document Type: Article

References (33)

1. Schoen C., Stritzker J., Goebel W., and Pilgrim S. Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol 294 5 (2004) 319-335
2. Garmory H.S., Leary S.E., Griffin K.F., Williamson E.D., Brown K.A., and Titball R.W. The use of live attenuated bacteria as a delivery system for heterologous antigens. J Drug Target 11 8-10 (2003) 471-479
3. Kochi S.K., Killeen K.P., and Ryan U.S. Advances in the development of bacterial vector technology. Expert Rev Vaccines 2 1 (2003) 31-43
4. Roland K.L., Tinge S.A., Killeen K.P., and Kochi S.K. Recent advances in the development of live attenuated bacterial vectors. Curr Opin Mol Ther 7 1 (2005) 62-72
5. Simonsen L., Kane A., Lloyd J., Zaffran M., and Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 77 10 (1999) 789-800
6. Murakami H., Kobayashi M., Zhu X., Li Y., Wakai S., and Chiba Y. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China. Soc Sci Med 57 10 (2003) 1821-1832
7. Bao J.X., and Clements J.D. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect Immun 59 10 (1991) 3841-3845
8. Kohler J.J., Pathangey L.B., Gillespie S.R., and Brown T.A. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin. Infect Immun 68 6 (2000) 3116-3120
9. Whittle B.L., and Verma N.K. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 15 16 (1997) 1737-1740
10. Attridge S.R., Davies R., and LaBrooy J.T. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine 15 2 (1997) 155-162
11. Vindurampulle C.J., and Attridge S.R. Vector priming reduces the immunogenicity of Salmonella-based vaccines in Nramp1+/+mice. Infect Immun 71 4 (2003) 2258-2261
12. Roberts M., Bacon A., Li J., and Chatfield S. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C. Infect Immun 67 8 (1999) 3810-3815
13. Sevil Domenech V.E., Panthel K., Meinel K.M., Winter S.E., and Russmann H. Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis. Microbes Infect 9 12-13 (2007) 1447-1453
14. Attridge S.R., and Vindurampulle C.J. Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery. Microb Pathog (2005)
15. de Aizpurua H.J., and Russell-Jones G.J. Oral vaccination Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med 167 2 (1988) 440-451
16. Gahan M.E., Webster D.E., Wesselingh S.L., and Strugnell R.A. Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium. Vaccine 25 (2007) 1476-1483
17. Fairweather N.F., Chatfield S.N., Makoff A.J., Strugnell R.A., Bester J., Maskell D.J., et al. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect Immun 58 5 (1990) 1323-1326
18. Clements J.D., Lyon F.L., Lowe K.L., Farrand A.L., and el-Morshidy S. Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin. Infect Immun 53 3 (1986) 685-692
19. Flo J., Tisminetzky S., and Baralle F. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine 19 13-14 (2001) 1772-1782
20. Shata M.T., Reitz Jr. M.S., DeVico A.L., Lewis G.K., and Hone D.M. Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine 20 3-4 (2001) 623-629
21. Cong H., Gu Q.M., Jiang Y., He S.Y., Zhou H.Y., Yang T.T., et al. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Parasite Immunol 27 1-2 (2005) 29-35
22. Ward S.J., Douce G., Figueiredo D., Dougan G., and Wren B.W. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun 67 5 (1999) 2145-2152
23. DiGiandomenico A., Rao J., and Goldberg J.B. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model. Infect Immun 72 12 (2004) 7012-7021
24. Kang H.Y., Srinivasan J., and Curtiss III R. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun 70 4 (2002) 1739-1749
25. Rooney J.F., Wohlenberg C., Cremer K.J., Moss B., and Notkins A.L. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J Virol 62 5 (1988) 1530-1534
26. Yei S., Mittereder N., Tang K., O'Sullivan C., and Trapnell B.C. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther 1 3 (1994) 192-200
27. Dunstan S.J., Simmons C.P., and Strugnell R.A. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect Immun 66 2 (1998) 732-740
28. Vindurampulle C.J., and Attridge S.R. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect Immun 71 1 (2003) 287-297
29. Kohler J.J., Pathangey L., Hasona A., Progulske-Fox A., and Brown T.A. Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors. Infect Immun 68 7 (2000) 4370-4373
30. Schutze M.P., Deriaud E., Przewlocki G., and LeClerc C. Carrier-induced epitopic suppression is initiated through clonal dominance. J Immunol 142 8 (1989) 2635-2640
31. Chabalgoity J.A., Villareal-Ramos B., Khan C.M., Chatfield S.N., de Hormaeche R.D., and Hormaeche C.E. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier. Infect Immun 63 7 (1995) 2564-2569
32. Dearlove C.E., Forrest B.D., van den Bosch L., and La Brooy J.T. The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a [letter]. J Infect Dis 165 1 (1992) 182-183
33. Metzger W.G., Mansouri E., Kronawitter M., Diescher S., Soerensen M., Hurwitz R., et al. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 22 17-18 (2004) 2273-2277